Back to search

Peptide record

TPDB19525

Antibacterial Anticancer Toxicity modified_plain modified
7 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB19525
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A 7-aa modified multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
FTVAXFI
Physicochemical Analysis
C36H52N6O8
RNDCEQGHLKMPSWY
F
696.84
6.02
0
0
5
-0
-2.53
2.200
111.43
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
1
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
0
L
0
K
0
M
2
F
0
P
0
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 0 K: 0 M: 0 F: 2 P: 0 S: 0 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
7
C36H52N6O8
696.84
6.02
-0
-2.53
2.200
Evidence Records 3 records
Evidence 1 Activity

Activity

<5% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
<5% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Purification and characterization of a novel anti-staphylococcal peptide (ASP-1) from bacillus sp. URID 12.1. | Int J Antimicrob Agents | 2018
Evidence 2 Activity

Activity

30% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
30% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Purification and characterization of a novel anti-staphylococcal peptide (ASP-1) from bacillus sp. URID 12.1. | Int J Antimicrob Agents | 2018
Evidence 3 Activity

Activity

% Hemolysis
Toxicity
5 %
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: <5% Hemolysis=128µg/ml 30% Hemolysis=256µg/ml | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Int J Antimicrob Agents. 2018 Jan 51(1):89-97.